ARCHIVES

Univ. of Rochester Leads Trial Of Combination Chemotherapy For Pancreatic Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Addition of Cobimetinib Boosts PFS in BRAF Mutation-Positive Patients in Phase III Trial

July 25, 2014

NIH May Claim BRCA1 Rights, While Myriad Files For Patent

October 7, 1994

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

May 21, 2004

Sales of Smoking Cessation Aids Increase, Effectiveness Drops

October 25, 2002

Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds.

December 14, 2001

ODAC Member Critical Of Amgen For Price Incentives.

March 21, 2008